Valuation: Victrex plc

Market Cap 581M 778M 681M 628M 1.1B 74.27B 1.12B 7.52B 2.95B 36.47B 2.92B 2.86B 126B P/E 2026 *
-88.4x
P/E 2027 * 14.5x
Enterprise Value 624M 836M 731M 674M 1.18B 79.77B 1.2B 8.07B 3.16B 39.17B 3.14B 3.07B 136B EV / Sales 2026 *
2.09x
EV / Sales 2027 * 2.04x
Free-Float
99.14%
Yield 2026 *
8.94%
Yield 2027 * 8.93%
1 day+11.49%
1 week+11.49%
Current month+11.49%
1 month+11.49%
3 months+17.83%
6 months+7.29%
Current year+7.29%
1 week 9.12
Extreme 9.12
9.12
1 month 9.12
Extreme 9.12
9.12
Current year 7.74
Extreme 7.74
10.8
1 year 7.74
Extreme 7.74
10.8
3 years 7.74
Extreme 7.74
20.03
5 years 7.74
Extreme 7.74
36.5
10 years 0
Extreme 0
45.68
Manager TitleAgeSince
Chief Executive Officer 53 2025-12-31
Director of Finance/CFO - 2022-07-03
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member 67 2018-02-08
Director/Board Member 70 2018-02-08
Director/Board Member 70 2020-04-30
Change 5-day change 1-year change 3-year change Capi.($)
+11.49%+11.49% - - 778M
-0.40%-3.65%+1.80%+48.87% 76.84B
+0.07%-2.48%-11.35%+16.88% 39.12B
+0.14%-7.27%-23.32%-34.19% 32.05B
+0.73%-0.97%+19.73%+30.07% 26B
-0.46%+1.91%+92.69%-6.50% 21.16B
+4.27%+1.65%+14.07%+5.19% 19.85B
-1.59%-3.66%-40.52%-36.19% 18.2B
-0.74%-5.27%+81.41%-45.93% 15.15B
-0.16%-3.24%-2.86%-5.39% 13.94B
Average +1.30%-2.67%+14.63%-3.02% 29.14B
Weighted average by Cap. +0.13%-2.89%+8.22%+10.06%

Financials

2026 *2027 *
Net sales 298M 400M 350M 323M 566M 38.16B 576M 3.86B 1.51B 18.74B 1.5B 1.47B 64.91B 314M 420M 368M 339M 596M 40.13B 606M 4.06B 1.59B 19.71B 1.58B 1.54B 68.26B
Net income -6.15M -8.25M -7.21M -6.65M -11.68M -787M -11.88M -79.66M -31.23M -386M -30.95M -30.28M -1.34B 39.5M 52.91M 46.29M 42.69M 74.97M 5.05B 76.22M 511M 200M 2.48B 199M 194M 8.59B
Net Debt 42.99M 57.6M 50.39M 46.46M 81.6M 5.5B 82.96M 556M 218M 2.7B 216M 212M 9.35B 58.59M 78.49M 68.66M 63.32M 111M 7.49B 113M 758M 297M 3.68B 295M 288M 12.74B
Logo Victrex plc
Victrex plc is a United Kingdom‑based materials company. The Company manufactures and sells high‑performance polymers and polymer solutions. It develops polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based materials, and produces semi‑finished and finished components, including thermoplastic polymers, engineered parts and biomaterial solutions. It operates across Sustainable Solutions and Medical segments, addressing aerospace, automotive, energy, industrial, electronics and healthcare applications, and provides polymer processing, design support, and material innovation services for implantable and non‑implantable medical devices, as well as industrial and engineering uses. The Company's subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component Manufacturing Limited, and Juvora Limited.
Employees
1,169
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
6.670GBP
Average target price
6.839GBP
Spread / Average Target
+2.53%

Quarterly revenue - Rate of surprise